Immunovant Sciences Gmbh

This study looks at the long-term safety and effectiveness of a drug called IMVT-1402 in adults with Graves' disease. Participants who finished earlier studies will be placed into one of three groups based on their disease status. The main goal is to see if people in Group A can …

This study looks at the long-term safety of a drug called batoclimab for adults with CIDP, a nerve disorder that causes weakness and numbness. About 108 people who completed a previous study will get weekly injections for up to a year. The goal is to see if the drug is safe and t…

This study tests a drug called batoclimab in 240 adults with generalized myasthenia gravis, a condition that causes muscle weakness. The goal is to see if it can improve daily activities and muscle strength better than a placebo. Participants receive injections weekly or every tw…